Market Overview

Benzinga's Top Initiations

Related THLD
Threshold Pharmaceuticals Announces Preclinical Data on Combination of Evofosfamide With Immune Checkpoint Inhibitors to Be Presented at the SITC 2015 Meeting
Threshold Pharmaceuticals Receives Two U.S. Patents for Tarloxotinib Bromide
Related ANV
Heron Therapeutics Initiates Phase 2 Clinical Trial of HTX-011 for the Treatment of Post-Operative Pain
Top Performing Industries For January 27, 2015

Analysts at William Blair initiated coverage on shares of Threshold Pharmaceuticals (NASDAQ: THLD) with an “outperform” rating. Threshold Pharmaceuticals' shares closed at $8.15 yesterday. Threshold Pharmaceuticals had $49.73 million in total cash for the latest quarter.

Scotia Capital initiated coverage on shares of Allied Nevada Gold (AMEX: ANV) with an “outperform” rating. Allied Nevada Gold's stock closed at $28.08 yesterday. Allied Nevada Gold's trailing-twelve-month operating margin is 35.98%.

JMP Securities initiated coverage on shares of Darling International (NYSE: DAR) with a “market perform” rating. Darling's shares closed at $16.18 yesterday. Darling's trailing-twelve-month revenue is $1.74 billion.

Analysts at Roth Capital initiated coverage on shares of Harmonic (NASDAQ: HLIT) with a “neutral” rating. Harmonic's shares closed at $4.21 yesterday. Harmonic's PEG ratio is 1.41.

Latest Ratings for THLD

Sep 2014Cantor FitzgeraldInitiates Coverage onBuy
Sep 2014HC WainwrightInitiates Coverage onBuy
Feb 2013Piper JaffrayUpgradesNeutralOverweight

View More Analyst Ratings for THLD
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (ANV + DAR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters